Found: 24
Select item for more details and to access through your institution.
Issue Information.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 3, doi. 10.1111/bjh.18250
- Publication type:
- Article
Rasburicase‐induced methaemoglobinaemia and catastrophic oxidative haemolysis in undiagnosed G6PD deficiency.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 7, doi. 10.1111/bjh.18464
- By:
- Publication type:
- Article
Spontaneous splenic rupture as initial presentation of diffuse large B‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 8, doi. 10.1111/bjh.18471
- By:
- Publication type:
- Article
British Journal of Haematology celebrates its 200th volume.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 9, doi. 10.1111/bjh.18599
- By:
- Publication type:
- Article
Immunomodulation for early‐onset haemolytic disease of the fetus/newborn: Can we delay the need for intrauterine transfusions?
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 11, doi. 10.1111/bjh.18457
- By:
- Publication type:
- Article
Do we have to exclude all relapsed diffuse large B‐cell lymphoma patients not in complete remission from autologous stem cell transplant?
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 13, doi. 10.1111/bjh.18468
- By:
- Publication type:
- Article
Should dexamethasone alone or in combination be the initial steroid for adult ITP: Still a relevant question.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 15, doi. 10.1111/bjh.18398
- By:
- Publication type:
- Article
Current and future therapies for haemophilia—Beyond factor replacement therapies.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 23, doi. 10.1111/bjh.18379
- By:
- Publication type:
- Article
Positron emission tomography derived metrics in relapsed or refractory large B‐cell lymphoma with residual disease before autologous stem cell transplant.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 35, doi. 10.1111/bjh.18441
- By:
- Publication type:
- Article
Real‐world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 45, doi. 10.1111/bjh.18479
- By:
- Publication type:
- Article
Allogeneic haematopoietic cell transplant in patients with relapsed/refractory anaplastic large cell lymphoma.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 54, doi. 10.1111/bjh.18467
- By:
- Publication type:
- Article
Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti‐leukaemic potential and alloreactivity across major human leukocyte antigen barriers.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 64, doi. 10.1111/bjh.18469
- By:
- Publication type:
- Article
Thymus and activation‐regulated chemokine (TARC) as treatment response marker for paediatric Hodgkin lymphoma: A pilot study.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 70, doi. 10.1111/bjh.18473
- By:
- Publication type:
- Article
Truncated CSF3 receptors induce pro‐inflammatory responses in severe congenital neutropenia.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 79, doi. 10.1111/bjh.18477
- By:
- Publication type:
- Article
Oculocerebrorenal syndrome of Lowe protein controls cytoskeletal reorganisation during human platelet spreading.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 87, doi. 10.1111/bjh.18478
- By:
- Publication type:
- Article
Decreased serum phosphate levels are a useful biomarker to predict occurrence and severity of cytokine release syndrome in chimeric antigen receptor T‐cell therapy.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. e1, doi. 10.1111/bjh.18504
- By:
- Publication type:
- Article
CAR‐T cell therapy is superior to standard of care as second‐line therapy for large B‐cell lymphoma: A systematic review and meta‐analysis.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. e4, doi. 10.1111/bjh.18506
- By:
- Publication type:
- Article
Is chimaeric antigen receptor T‐cell therapy really superior to standard of care as second‐line therapy for large B‐cell lymphoma?
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. e6, doi. 10.1111/bjh.18505
- By:
- Publication type:
- Article
Identification of haemolytic anaemia caused by glucose phosphate isomerase deficiency in a thalassaemia‐endemic region: Correction of misdiagnosis and consideration of the cause of misdiagnosis.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. e8, doi. 10.1111/bjh.18512
- By:
- Publication type:
- Article
Intravenous immunoglobulin in the management of severe early onset red blood cell alloimmunisation.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 100, doi. 10.1111/bjh.18449
- By:
- Publication type:
- Article
Allogeneic haematopoietic cell transplant in patients with relapsed/refractory anaplastic large cell lymphoma—Response.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 107, doi. 10.1111/bjh.18528
- By:
- Publication type:
- Article
Anti‐IFC antibodies in a patient with CHAPLE syndrome: Implications for blood management.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 109, doi. 10.1111/bjh.18509
- By:
- Publication type:
- Article
Blood Cells 3E: Morphology & Clinical Relevance.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 113, doi. 10.1111/bjh.18482
- By:
- Publication type:
- Article
A novel ATRX variant with splicing consequences in myelodysplastic syndrome with acquired alpha thalassaemia.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. e13, doi. 10.1111/bjh.18525
- By:
- Publication type:
- Article